Comparison of results after flouroquinolons and combination therapies in type iiiA chronic prostatitis;Comparación de los resultados después de flouroquinolonas y terapias de combinación en prostatitis crónica tipo iiiA

Actas Urologicas Espanolas

Volumn 37, Issue 10, 2013, Pages 619-624

  Altintas, R ^a   Oguz, F ^a   Beytur, A ^a   Ediz, C ^a   Gunes, A ^a   Ozer, A ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Alpha blocker; Chronic prostatitis; Fluoroquinolones

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; QUINOLONE DERIVATIVE; SULFONAMIDE; TAMSULOSIN;

ADULT; AGED; ARTICLE; BLOQUEADOR ALFA; CHRONIC DISEASE; CHRONIC PROSTATITIS; CLASSIFICATION; COMPARATIVE STUDY; DRUG COMBINATION; FLUOROQUINOLONAS; HUMAN; MALE; MIDDLE AGED; PROSTATITIS; PROSTATITIS CRÓNICA; RETROSPECTIVE STUDY; YOUNG ADULT;

ALPHA BLOCKER; BLOQUEADOR ALFA; CHRONIC PROSTATITIS; FLUOROQUINOLONAS; FLUOROQUINOLONES; PROSTATITIS CRÓNICA;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PROSTATITIS; RETROSPECTIVE STUDIES; SULFONAMIDES; YOUNG ADULT;

EID: 84886946045     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2012.11.018     Document Type: Article

References (22)

1. D.S. Schiller, and A. Parikh Identification, pharmacologic considerations, and management of prostatitis Am J Geriatr Pharmacother 91 2011 37 48
2. N.A. Daniels, S.K. Ewing, J.M. Zmuda, T.J. Wilt, D.C. Bauer Osteoporotic Fractures in Men (MrOS) Research Group Correlates and prevalence of prostatitis in a large community-based cohort of older men Urology 66 2005 964 970
3. F.H. Netter Atlas of human anatomy 5th ed 2010 Ciba-Geigy Corporation Summit, NJ
4. J.N. Kreiger, L. Nyberg, and J.C. Nickel NIH consensus definition and classification of prostatitis JAMA 281 1999 236 237
5. J.A. Kreiger Prostatitis sydromes: Pathophysiology, differential diagnosis, and treatment Sex Transm Dis 11 1984 100 112
6. D.A. Shoskes, L. Hakim, G. Ghoniem, and C.L. Jackson Longterm results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome J Urol 169 2003 1406 1410
7. J. Lugg, J. Lettiere, H. Stass, and V. Agarwal Determination of the concentration of ciprofloxacin in prostate tissue following administrtaion of a single, 1,000 mg, extended release dose J Chemother 20 2008 213 218
8. G.L. Drusano, S.L. Preston, M. Van Guilder, D. North, M. Gombert, and M. Oefelein A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin Antimicrob Agents Chemother 44 2000 2046 2051
9. W. Bundrick, S.P. Heron, P. Ray, W.M. Schiff, A.M. Tennenberg, and B.A. Wiesinger Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prosatitis: A randomized double-blind multicenter study Urology 62 2003 537 541
10. P.Y. Cheah, M.L. Liong, K.H. Yuen, C.L. Teh, T. Khor, and J.R. Yang Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: A randomized, placebo controlled trial J Urol 169 2003 592 596
11. J.C. Nickel, P. Narayan, J. Mckay, and C. Doyle Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: A randomized double blind trial J Urol 171 2004 1594 1597
12. R.B. Alexander, K.J. Propert, A.J. Schaeffer, J.R. Landis, J.C. Nickel, and M.P. O'Leary Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: A randomized double-blind trial Ann Inten Med 141 2004 581 589
13. W. Hochreiter, M. Ludwig, W. Weidner, F. Wagenlehner, K. Naber, and S. Eremenco National Institutes of Health NIH chronic prostatitis symptom index The German version Urologe A 401 2001 16 17
14. K.J. Propert, M.S. Litwin, Y. Wang, R.B. Alexander, E. Calhoun, and J.C. Nickel Responsiveness of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Qual Life Res 15 2006 299 305
15. B.A. Lipsky, I. Byren, and C.T. Hoey Treatment of bacterial prostatitis Clin Infect Dis 50 2010 1641 1652
16. T.E. Bjerklund Johansen, R.N. Gruneberg, J. Guibert, A. Hofstetter, B. Lobel, and K.G. Naber The role of antibiotics in the treatment of chronic prostatitis: A consensus statement Eur Urol 346 1998 457 466
17. F.M. Wagenlehner, W. Weidner, F. Sörgel, and K.G. Naber The role of antibiotics in chronic bacterial prostatitis Int J Antimicrob Agents 261 2005 1 7
18. Z.Q. Ye, R.Z. Lan, W.M. Yang, L.F. Yao, and X. Yu Tamsulosin treatment of chronic non-bacterial prostatitis J Internat Med Res 36 2008 244 252
19. C.W. Jeong, D.J. Lim, H. Son, S.E. Lee, and H. Jeong Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination Urol Int 802 2008 157 161
20. K.G. Naber, M. Kinzig, F. Sörgel, and D.I. Weigel Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid Infection 212 1993 98 100
21. B. Kulovac, D. Aganović, A. Prcić, and O. Hadziosmanović Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome Basic Med Sci 73 2007 245 249
22. B. Shen, X. Jin, S. Cai, J. Chen, G. Chen, and W. Zhao Effect and mechanism of alpha1-adrenoceptor blocker combined with antibiotics for chronicprostatitis Zhonghua Nan Ke Xue 107 2004 518 520